FDA inspection
Pfizer Manufacturing Deutschland GmbH: FDA inspection ending May 11, 2023
FDA inspection 1222873 · Voluntary Action Indicated (VAI) · Freiburg Im Breisgau
Key facts
| Inspection ID | 1222873 |
|---|---|
| Firm | Pfizer Manufacturing Deutschland GmbH |
| FEI number | 3002807097 |
| Address | Pfizer Gmbh Arzneimittelwerk Godecke, Mooswaldallee 1 |
| City | Freiburg Im Breisgau |
| Country | Germany |
| Fiscal year | 2023 |
| Inspection end date | May 11, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data